Acumen Pharmaceuticals, Inc. — Director's Dealing 2021

Jul 8, 2021

SEC Form 3/A — Form 3/A

Issuer: Acumen Pharmaceuticals, Inc. (ABOS)
CIK: 0001576885
Period of Report: 2021-06-30

Reporting Person: Stalfort John A III (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series B Preferred	$		Common Stock (131595)		Indirect

Footnotes

F1: Each share of Series B Preferred Stock will automatically convert into the same number of shares of Common Stock of the Issuer upon the closing of the Issuer's initial public offering. The Series B Preferred Stock has no expiration date.

F2: These shares were omitted from the reporting person's original Form 3.

F3: The securities are held by Gineane Holly Stalfort, as Trustee of the John A. Stalfort III 2018 Irrevocable Trust under agreement dated as of October 25, 2018.